Whether benign or malignant, the main cause of symptoms in tracheal tumors is the obstruction of the lumen and respiratory difficulties. Only when the tracheal lumen is blocked by 1/2 to 2/3 does severe respiratory difficulty occur. Common symptoms in tracheal tumor patients include dry cough, shortness of breath, asthma, wheezing, dyspnea, cyanosis, etc. Physical activity, changes in body position, and tracheal secretions can all worsen symptoms. Malignant lesions may cause hoarseness, difficulty swallowing, etc. Recurrent episodes of unilateral or bilateral pneumonia may occur. If the lesion is located at the junction of one tracheal bronchus, even if the tracheal stenosis is very obvious, only one side of pneumonia can be seen. If the tumor is located in the trachea, bilateral pneumonia can be seen. In addition to symptoms of tracheal obstruction, persistent and stubborn cough is also a clinical manifestation of primary tracheal tumors. Whether benign or malignant, when the lumen is not completely blocked, it often manifests as purulent infection of the lung, bronchiectasis, lung abscess, etc.; when the lumen is completely obstructed, it manifests as atelectasis.
1. Characteristics of various benign tracheal tumors
1. Papilloma:
Papillomas are common in the larynx, while papillomas originating from the bronchial tree are rare. This disease is more common in children, less common in adults. In children, it is often multiple, while in adults, it is solitary and can undergo malignant transformation. The etiology may be related to inflammatory reactions caused by viral infections. Papillomas originate from the tracheal and bronchial mucosa, presenting as irregular papillary villous protrusions, with vascular connective tissue as the core, covered by several layers of differentiated mature epithelial cells arranged radially. The superficial layer is squamous epithelial cells, which are keratinized.
The tracheal wall phase, CT is helpful for diagnosis, and fiberoptic bronchoscopy is a reliable method for definite diagnosis. Under bronchoscopy, papillomas appear like cauliflower, pale red, fragile and prone to bleeding. The base is wide or has a thin pedicle. Preparations should be made for biopsy to avoid bleeding or tumor detachment causing asphyxiation.
Tracheal papillomas grow in clusters, attached to the tracheobronchial mucosa through a finer pedicle. Papillomas are brittle and easily fall off. Papillomas have the characteristics of multifocality and postoperative recurrence. According to the clinical experience of large groups of tracheal tumor surgical treatments, no treatment method can prevent the recurrence tendency, which brings certain difficulties to clinical treatment.
Small benign papillomas can be removed through fibrobronchoscopy, or treated with laser therapy through fibrobronchoscopy, or removed by tracheotomy. For those with a larger size, broader base, and suspected malignancy, sleeve resection of the trachea or limited resection of the lateral wall of the trachea should be performed.
2. Fibroma:
Tracheal fibromas are rare, with the tumor surface covered by normal tracheal mucosa. Under bronchoscopy, the tumor appears as a circular, grayish-white mass with a smooth surface, a broad base, non-mobile, and not easy to bleed. It often appears with multiple biopsies all being negative.
3. Hemangioma:
They can be cavernous hemangiomas, vascular endothelioma, vascular pericytoma, etc., and can originate from the trachea or extend into the trachea from the mediastinal hemangioma. Hemangiomas can diffusely infiltrate the tracheal mucosa and narrow the tracheal lumen, or they can protrude into the tracheal lumen to cause obstruction. Under fibrobronchialscopy, the hemangiomas protruding into the lumen are soft, red, and polypoid. Biopsy is generally prohibited to avoid bleeding and asphyxia. Treatment can be endoscopic resection, laser therapy, or surgical operation.
4. Neurofibroma:
Tracheal nerve sheath tumors are benign tumors of the nerve sheath, often solitary, encapsulated, hard in texture, and the tumor can be pedunculated and protrude into the tracheal lumen. Under fibrobronchoscopy, circular, hard, and smooth masses can be seen on the tracheal wall. Histologically, there is an alternation of spindle cells and mucinous matrix, and the nerve sheath cells are arranged in a typical lattice pattern. Tracheal nerve sheath tumors can be removed endoscopically or by tracheotomy.
5. Fibrous histiocytoma:
Tracheal fibrous histiocytoma is rare, commonly located in the upper third of the trachea, presenting as a polypoid mass, soft in texture, and grayish-white. It protrudes into the lumen. It is difficult to differentiate between benign and malignant histologically, mainly based on whether the tumor has invaded externally, metastasized, and has a large number of nuclear mitotic figures. Fibrous histiocytoma often recurs locally after resection, so the surgical range can be wider, and local extended resection or sleeve resection of the trachea should be performed. Postoperative treatment of malignant fibrous histiocytoma of the trachea should be supplemented with radiotherapy and chemotherapy.
6. Lipoma:
Tracheal lipomas are extremely rare, originating from differentiated mature fat cells or primitive mesenchymal cells. Subtle red or yellow circular masses can be seen under the fibrobronchial tube, blocking the lumen, with a smooth surface, mostly broad-based, sometimes with a short pedicle, covered by bronchial mucosa, and soft in texture. Tracheal lipomas can be removed through bronchoscopy and the base burned with a laser. When the tumor is large and has penetrated the cartilage ring into the trachea, local resection of the tracheal wall or sleeve resection of the trachea should be performed.
7. Cartilaginous tumor:
Tracheal cartilaginous tumors are extremely rare, with only a few case reports in the literature. The tumors are round, hard, and white, with part located within the tracheal wall and part protruding into the tracheal lumen. Small cartilaginous tumors can generally be removed through bronchoscopy, and recurrence and malignant transformation can occur after tracheal cartilaginous tumor surgery.
8. Leiomyoma:
Tracheal leiomyoma often occurs in the lower third of the trachea, originating from the submucosal layer of the trachea. It is round or oval, with a smooth surface, protruding into the lumen. The mucosa is pale. Histologically, the tumor is composed of well-differentiated, arranged in a crisscross pattern of fusiform cell bundles. Tracheal leiomyoma grows slowly, and it can be removed through fiberoptic bronchoscopy when the tumor is small. When the tumor is larger, a sleeve resection of the trachea should be performed.
9. Hamartoma:
The tumor is round or oval, with a complete capsule, usually with a small pedicle connected to the wall of the tracheobronchus. The tumor surface is smooth and hard, and it is not easy to obtain tumor tissue with fiberoptic bronchoscope biopsy forceps. Treatment can be laser ablation, vaporization of the tumor, or removal with biopsy forceps.
Two, Characteristics of Malignant Tumors of the Trachea
1. Tracheal squamous cell carcinoma:
It commonly occurs in the lower third of the trachea, accounting for 40% to 50% of primary tracheal malignant tumors. It can manifest as a well-localized protruding lesion or an ulcerative type, showing infiltrative growth. It is prone to invade the recurrent laryngeal nerve and esophagus. Scattered multiple squamous cell carcinomas in the trachea can occasionally be seen, and ulcerative squamous cell carcinomas can also involve the entire length of the trachea. About one-third of primary tracheal squamous cell carcinoma patients have deep mediastinal lymph node and lung metastasis at the time of initial diagnosis. The spread of tracheal squamous cell carcinoma often occurs first in the adjacent paratracheal lymph nodes or directly invades the mediastinal structures.
2. Tracheal adenoid epithelial carcinoma:
They account for about 10% of tracheal malignant tumors, with small size, hard texture, and little necrosis. Patients often have deep invasion of the tumor at the time of consultation, with poor prognosis. Other rare tracheal carcinomas include oat cell carcinoma. Malignant tumors originating from the tracheal stroma include leiomyosarcoma, chondrosarcoma, liposarcoma, etc. Carcinoma and chondrosarcoma of the trachea may be cured by surgical resection.
Three, Characteristics of Low-Grade Malignant Tumors of the Trachea
1. Carcinoid:
Kulchitsky cells originating from the tracheobronchial mucosa contain neurosecretory granules. Pathologically, they are divided into typical carcinoids and atypical carcinoids. Carcinoids are commonly found in the main bronchus and its distal bronchi. Clinical symptoms are related to the location of the tumor. Carcinoids located in the main bronchus can cause recurrent lung infections, expectoration of blood-tinged sputum, or hemoptysis. A few carcinoids are accompanied by carcinoid syndrome and Cushing syndrome. Fiberoptic bronchoscopy can determine the location of the tumor and directly observe its shape. Pathological diagnosis can be obtained through biopsy, but the positive rate of biopsy is only about 50%, because Kulchitsky cells are distributed in the basal layer of the bronchial mucosal epithelium. The surface of the tumor growing inward often covers a complete mucosal epithelium, so it is not easy to obtain tumor tissue during biopsy. The principle of surgical treatment for tracheobronchial carcinoids is to remove the tumor as much as possible while retaining the normal tissue to the maximum extent. For tumors located in the main bronchus, middle segment, and lobar bronchi, if there are no obvious irreversible changes in the distal part of the patient, bronchoplasty should be attempted. If there is lymph node metastasis at the hilum of the lung, simultaneous pulmonary hilum lymph node dissection should be performed. If the distal lung tissue has obvious irreversible changes due to repeated infections, lobectomy or pneumonectomy should be performed. Carcinoids are somewhat sensitive to radiotherapy, and adjuvant radiotherapy can be used after surgery.
The prognosis of surgical treatment for tracheobronchial carcinoid is good, with a 5-year survival rate of up to 90%, while the prognosis of atypical carcinoid is relatively poor.
2. Adenoid cystic carcinoma:
Adenoid cystic carcinoma is more common in women, with about 2/3 occurring in the lower segment of the trachea, near the carina and the starting level of the right and left main bronchi. The tumor originates from the mucous secretion cells of the gland ducts or glands and can grow like a polyp. However, it often infiltrates circumferentially along the tissue between the tracheal cartilage rings, blocking the lumen. It can also directly invade the surrounding lymph nodes. Tumors that protrude into the lumen of the trachea usually do not have a complete mucosal covering, but they rarely form ulcers. The adenoid cystic carcinoma at the carina can grow into both main bronchi.
Adenoid cystic carcinoma is histologically divided into pseudo-acinar type and medullary type. The presence of PAS-positive mucus within and outside the cells is its main characteristic. Adenoid cystic carcinoma has the characteristic of slow growth in clinical practice, and the course of the disease can be very long. Even if distant metastasis occurs, its clinical behavior is relatively benign. Large tracheal adenoid cystic carcinomas often cause mediastinal displacement first. The adenoid cystic carcinoma of the trachea can infiltrate and grow along the submucosal layer of the trachea, involving a long segment of the trachea, and it is not distinguishable grossly. Some lesions have a higher degree of malignancy, and there are already metastases to the pleura and lung before the primary tumor in the trachea is discovered. Almost all patients with tracheal adenoid cystic carcinoma seen in clinical practice have undergone repeated local resection or segmental resection of the tracheal tumor, and these patients often have distant metastasis.
Treatment includes surgical resection, endoscopic resection or laser treatment, and chemotherapy can be used as adjuvant therapy. Adenoid cystic carcinoma is not very sensitive to radiotherapy, but it can be used for cases where the lesion cannot be completely resected, there is mediastinal lymph node metastasis, or there are surgical contraindications.
3. Mucinous epidermoid carcinoma:
The incidence is relatively low, and it mostly occurs in the main bronchus, the middle segment bronchus, and the lobar bronchus. The tumor surface is generally covered with mucosa, and its clinical manifestations are closely related to the location of the tumor. Pathological diagnosis can be confirmed by bronchoscope biopsy.
Mucinous epidermoid carcinoma has infiltrative characteristics in clinical practice, and it metastasizes along the lymphatic pathway. Surgical treatment includes pulmonary lobectomy or total pneumonectomy, lymph node dissection at the hilum and mediastinum, and adjuvant radiotherapy after surgery. Mucinous epidermoid carcinoma is prone to recurrence after surgery, and its prognosis is worse than that of adenoid cystic carcinoma and carcinoid.